ABOUT THIS STUDY
- Mild-to-Moderate Alzheimer's disease
- MMSE score 10-24 inclusive
- Administration of anti-dementia drugs including cholinesterase-inhibitors or NMDA
receptor antagonists within 90 days
- Complication of other causes of dementia
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.